Evaluation of the Strength of Handgrip in Patients With Pulmonary Artery Hypertension

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

55 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-09-01

Study Completion Date

2023-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Our study aims to investigate the changes in muscle strength and muscle mass in PAH patients compared to healthy individuals and determine its effects on prognosis.

Further categorization of PAH patients based on their NYHA class will help determine if their handgrip strength decreases while progressing from NYHA class 1 to 4. This in turn allows us to examine if the handgrip test can be considered as an alternative to a 6-minute walking test (6MWT).

The Jamar Hydraulic Hand Dynamometer device in our hospital is used for measuring the handgrip strength test.

The data of the included subjects in this study are obtained and recorded from the existing files. Also, the handgrip strength test data will be recorded after the investigation

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of Respiratory Muscle in Patient With Pulmonary Arterial Hypertension

NCT05056532

Pulmonary Artery Hypertension

COMPLETED

Aerobic Exercise Training in Pulmonary Arterial Hypertension

NCT02371733

Pulmonary Arterial Hypertension

COMPLETED NA

Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass

NCT07132788

Pulmonary Hypertension

ACTIVE_NOT_RECRUITING

Exercise Training in Patients With Pulmonary Arterial Hypertension

NCT05242380

Pulmonary Arterial Hypertension

COMPLETED NA

Hand Grip Strength and Medical Research Council Scale as Predictors of Weaning Failure

NCT03991702

Muscle Weakness Condition Mechanical Ventilation Complication Weaning Failure

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In our study, dynamometer tests will be applied to approximately 15 patients diagnosed with PAH. For control purposes, a hand dynamometer test will be applied to 40 healthy children. Patients' age, gender, weight, height, NYHA class, used medications, complete blood count (Hb, Hct, MCV, RDW), BNP, Troponin-t, biochemical parameters, catheterization findings at diagnosis, Echocardiographic findings (Tricuspid Annular Plane Systolic Excursion-TAPSE), Right Ventricular End Systolic Remodeling Index (RVES-RI), Pulmonary Artery acceleration Time (PAaccT), Tricuspid Velocity Time Integral (TR-VTI), RV area, RV length, Right Ventricular Load Adaptation Index (RV LAI), congenital heart disease and whether there is a shunt recorded or not. Patients are informed about the test before the dynamometer test. This may affect the integrity and accuracy of test results. To prevent such inaccuracies, the test will be performed on patients' both hands and the results are not recorded. Patients are asked to sit in a specific position. That is to sit upright with their elbows flexed 90° and the palms facing inwards (medially). Then, the test is performed 3 times with both hands. The results are recorded as the average of all the trials for dominant and non-dominant hands separately. The length of patients' hands is also measured. With the help of this test,it is possible to measure the difference in handgrip strength between healthy subjects and PAH patients. Additionally, patients are divided into 4 groups based on their NYHA classes. This will investigate if the patients' handgrip strength decreases as progress from NYHA class 1 to 4

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

This study includes 15 patients diagnosed with Pulmonary Hypertension in Gazi Medical School Hospital Department of Pediatric Cardiology and 40 healthy children who applied to Gazi University Medical School Pediatric Cardiology Clinic

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pulmonary Hypertension

Group Type ACTIVE_COMPARATOR

Handgrip strength test

Intervention Type DIAGNOSTIC_TEST

The Jamar Hydraulic Hand Dynamometer device is used for measuring the handgrip strength test

Healthy Control

Group Type ACTIVE_COMPARATOR

Handgrip strength test

Intervention Type DIAGNOSTIC_TEST

The Jamar Hydraulic Hand Dynamometer device is used for measuring the handgrip strength test

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Handgrip strength test

The Jamar Hydraulic Hand Dynamometer device is used for measuring the handgrip strength test

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Pulmonary Hypertension Group:

* Diagnosed with Pulmonary Hypertension and attending the clinic for follow-ups.
* Older than 5 years.

Healthy Control Group

* Individuals without any known diseases, structural Cardiac anomalies, familial history of heart diseases and sudden death.
* Older than 5 years.

Exclusion Criteria

Volunteers' Rejection Criteria:

* Younger than 5 years.
* Mental state disorders which will cause inaccuracies in the study's

i. Volunteers' Dismissal Criteria:
* Inadaptation to the study's steps.
* If subjects become reluctant to continue with the study.

Minimum Eligible Age

5 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes